132 related articles for article (PubMed ID: 12814187)
1. Immunohistochemical characterization of canine intestinal epithelial and mesenchymal tumours with a monoclonal antibody to hepatocyte paraffin 1 (Hep Par 1).
Ramos-Vara JA; Miller MA
Histochem J; 2002; 34(8-9):397-401. PubMed ID: 12814187
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical characterization of canine hyperplastic hepatic lesions and hepatocellular and biliary neoplasms with monoclonal antibody hepatocyte paraffin 1 and a monoclonal antibody to cytokeratin 7.
Ramos-Vara JA; Miller MA; Johnson GC
Vet Pathol; 2001 Nov; 38(6):636-43. PubMed ID: 11732796
[TBL] [Abstract][Full Text] [Related]
3. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study.
Villari D; Caruso R; Grosso M; Vitarelli E; Righi M; Barresi G
Pathology; 2002 Oct; 34(5):423-6. PubMed ID: 12408340
[TBL] [Abstract][Full Text] [Related]
4. Expression of hepatocyte antigen in small intestinal epithelium and adenocarcinoma.
Mac MT; Chung F; Lin F; Hui P; Balzer BL; Wang HL
Am J Clin Pathol; 2009 Jul; 132(1):80-5. PubMed ID: 19864237
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract.
Maitra A; Murakata LA; Albores-Saavedra J
Am J Clin Pathol; 2001 May; 115(5):689-94. PubMed ID: 11345832
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity of hepatocyte paraffin 1 monoclonal antibody in cutaneous metastatic tumors.
Kanitakis J; Chouvet B; Claudy A; Scoazec JY
Am J Clin Pathol; 2004 Jul; 122(1):85-9. PubMed ID: 15272534
[TBL] [Abstract][Full Text] [Related]
7. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte Paraffin 1 Immunoreactivity in Early Colon Carcinogenesis.
Nemolato S; Ravarino A; Fanni D; Coni P; Di Felice E; Senes G; Faa G
Gastroenterology Res; 2009 Oct; 2(5):277-281. PubMed ID: 27956971
[TBL] [Abstract][Full Text] [Related]
9. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
Chu PG; Ishizawa S; Wu E; Weiss LM
Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte antigen (Hep Par 1) is helpful in distinguishing between inflamed and architecturally altered ileal and colonic mucosa.
Groisman GM; Amar M; Meir A
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):392-6. PubMed ID: 22710817
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma.
Kakar S; Muir T; Murphy LM; Lloyd RV; Burgart LJ
Am J Clin Pathol; 2003 Mar; 119(3):361-6. PubMed ID: 12645337
[TBL] [Abstract][Full Text] [Related]
13. Canine intestinal adenocarcinoma and carcinoid.
Patnaik AK; Hurvitz AI; Johnson GF
Vet Pathol; 1980 Mar; 17(2):149-63. PubMed ID: 7361376
[TBL] [Abstract][Full Text] [Related]
14. Immunohistological evaluation of single small hepatocellular carcinoma with negative staining of monoclonal antibody Hepatocyte Paraffin 1.
Sugiki T; Yamamoto M; Aruga A; Takasaki K; Nakano M
J Surg Oncol; 2004 Nov; 88(2):104-7. PubMed ID: 15499598
[TBL] [Abstract][Full Text] [Related]
15. Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma.
Hanif R; Mansoor S
J Coll Physicians Surg Pak; 2014 Mar; 24(3):186-9. PubMed ID: 24613115
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples.
Lugli A; Tornillo L; Mirlacher M; Bundi M; Sauter G; Terracciano LM
Am J Clin Pathol; 2004 Nov; 122(5):721-7. PubMed ID: 15491968
[TBL] [Abstract][Full Text] [Related]
17. Does Hepatocyte Paraffin 1 expression stand a role in determining the site origin of an adenocarcinoma from unknown gastrointestinal primary?
Yadav R; Chopra S; Garg A; Gupta B; Kinra P; Gupta SD; Das P
Indian J Pathol Microbiol; 2016; 59(4):474-480. PubMed ID: 27721277
[TBL] [Abstract][Full Text] [Related]
18. Glypican-3 is useful but not superior to Hep Par 1 in differentiating hepatocellular carcinoma from other liver tumours.
Pour AM; Masir N; Rose IM
Malays J Pathol; 2016 Dec; 38(3):229-233. PubMed ID: 28028292
[TBL] [Abstract][Full Text] [Related]
19. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma.
Leong AS; Sormunen RT; Tsui WM; Liew CT
Histopathology; 1998 Oct; 33(4):318-24. PubMed ID: 9822920
[TBL] [Abstract][Full Text] [Related]
20. Role of Hepatocyte Paraffin 1 antigen in the course of colorectal carcinogenesis.
Abu-Zeid RM; Farid RM
Int J Physiol Pathophysiol Pharmacol; 2013; 5(3):177-83. PubMed ID: 24044037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
